To develop peptide hydrogels for creating 3D lung cancer models that mimic the tumor environment.
Utilized peptide hydrogelators with MMP-2 degradation properties
Encapsulated A549 cells within the hydrogels
Created 3D models for testing anticancer efficacy
Successful encapsulation of A549 lung cancer cells
Development of 3D models that can be used for anticancer drug testing
Hydrogels show degradation properties specific to MMP-2
Abstract
Novel peptide hydrogelators with MMP-2 degradation properties were utilized to encapsulate A549 cells, thereby creating 3D lung cancer models for testing anticancer drugs.